beta blocker: be given before surgery

Related concepts

Parents	agent Weight: 0.65 , high blood pressure Weight: 0.63 , heart disease Weight: 0.63 , vasodilator Weight: 0.62
Siblings	atenolol Weight: 0.53 , lung cancer Weight: 0.33 , cystic fibrosis Weight: 0.33 , agonist Weight: 0.32 , blood clot Weight: 0.32

Related properties

Property	Similarity
be given before surgery	1.00
be important before surgery	0.95
form after surgery	0.93
happen after surgery	0.93
be more likely after surgery	0.92
occur after surgery	0.91
be risk after surgery	0.91
be common after surgery	0.90
form after knee surgery	0.88
be given to heart attack patients	0.77

Priors about this statement

Cues

Evidence

Clauses

Remarkability exclusitivity between siblings

0.11

Rule weight: 0.13
Evidence weight: 0.87
Similarity weight: 0.92

Evidence: 0.34

¬ Remarkable(beta blocker, be given before surgery) ⋁

Evidence: 0.40

¬ Remarkable(blood clot, be more likely after surgery)

0.11

Rule weight: 0.13
Evidence weight: 0.88
Similarity weight: 0.91

Evidence: 0.34

¬ Remarkable(beta blocker, be given before surgery) ⋁

Evidence: 0.36

¬ Remarkable(blood clot, be risk after surgery)

0.10

Rule weight: 0.13
Evidence weight: 0.81
Similarity weight: 0.93

Evidence: 0.34

¬ Remarkable(beta blocker, be given before surgery) ⋁

Evidence: 0.55

¬ Remarkable(blood clot, happen after surgery)

0.10

Rule weight: 0.13
Evidence weight: 0.80
Similarity weight: 0.93

Evidence: 0.34

¬ Remarkable(beta blocker, be given before surgery) ⋁

Evidence: 0.58

¬ Remarkable(blood clot, form after surgery)

0.10

Rule weight: 0.13
Evidence weight: 0.81
Similarity weight: 0.90

Evidence: 0.34

¬ Remarkable(beta blocker, be given before surgery) ⋁

Evidence: 0.56

¬ Remarkable(blood clot, be common after surgery)

...

Remarkability from sibling implausibility

0.47

Rule weight: 0.60
Evidence weight: 0.89
Similarity weight: 0.88

Evidence: 0.34

Plausible(beta blocker, be given before surgery) ⋁

Evidence: 0.74

Remarkable(blood clot, form after knee surgery) ⋁

Evidence: 0.66

¬ Plausible(blood clot, form after knee surgery)

0.46

Rule weight: 0.60
Evidence weight: 0.84
Similarity weight: 0.91

Evidence: 0.34

Plausible(beta blocker, be given before surgery) ⋁

Evidence: 0.70

Remarkable(blood clot, occur after surgery) ⋁

Evidence: 0.80

¬ Plausible(blood clot, occur after surgery)

0.45

Rule weight: 0.60
Evidence weight: 0.81
Similarity weight: 0.93

Evidence: 0.34

Plausible(beta blocker, be given before surgery) ⋁

Evidence: 0.58

Remarkable(blood clot, form after surgery) ⋁

Evidence: 0.68

¬ Plausible(blood clot, form after surgery)

0.43

Rule weight: 0.60
Evidence weight: 0.77
Similarity weight: 0.93

Evidence: 0.34

Plausible(beta blocker, be given before surgery) ⋁

Evidence: 0.55

Remarkable(blood clot, happen after surgery) ⋁

Evidence: 0.78

¬ Plausible(blood clot, happen after surgery)

0.40

Rule weight: 0.60
Evidence weight: 0.74
Similarity weight: 0.91

Evidence: 0.34

Plausible(beta blocker, be given before surgery) ⋁

Evidence: 0.36

Remarkable(blood clot, be risk after surgery) ⋁

Evidence: 0.61

¬ Plausible(blood clot, be risk after surgery)

...

Salient implies Plausible

0.23

Rule weight: 0.28
Evidence weight: 0.80
Similarity weight: 1.00

Evidence: 0.34

Plausible(beta blocker, be given before surgery) ⋁

Evidence: 0.30

¬ Salient(beta blocker, be given before surgery)

Similarity expansion

0.57

Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.77

Evidence: 0.34

Remarkable(beta blocker, be given before surgery) ⋁

Evidence: 0.20

¬ Remarkable(beta blocker, be given to heart attack patients)

0.56

Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.77

Evidence: 0.30

Salient(beta blocker, be given before surgery) ⋁

Evidence: 0.21

¬ Salient(beta blocker, be given to heart attack patients)

0.55

Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.77

Evidence: 0.34

Plausible(beta blocker, be given before surgery) ⋁

Evidence: 0.25

¬ Plausible(beta blocker, be given to heart attack patients)

0.49

Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.77

Evidence: 0.47

Typical(beta blocker, be given before surgery) ⋁

Evidence: 0.49

¬ Typical(beta blocker, be given to heart attack patients)

0.46

Rule weight: 0.85
Evidence weight: 0.56
Similarity weight: 0.95

Evidence: 0.47

Typical(beta blocker, be given before surgery) ⋁

Evidence: 0.83

¬ Typical(beta blocker, be important before surgery)

...

Typical and Remarkable implies Salient

0.12

Rule weight: 0.14
Evidence weight: 0.89
Similarity weight: 1.00

Evidence: 0.30

Salient(beta blocker, be given before surgery) ⋁

Evidence: 0.47

¬ Typical(beta blocker, be given before surgery) ⋁

Evidence: 0.34

¬ Remarkable(beta blocker, be given before surgery)

Typical implies Plausible

0.33

Rule weight: 0.48
Evidence weight: 0.69
Similarity weight: 1.00

Evidence: 0.34

Plausible(beta blocker, be given before surgery) ⋁

Evidence: 0.47

¬ Typical(beta blocker, be given before surgery)

Typicality and Rermarkability incompatibility between siblings

0.09

Rule weight: 0.14
Evidence weight: 0.75
Similarity weight: 0.93

Evidence: 0.34

¬ Remarkable(beta blocker, be given before surgery) ⋁

Evidence: 0.73

¬ Typical(blood clot, form after surgery)

0.09

Rule weight: 0.14
Evidence weight: 0.78
Similarity weight: 0.88

Evidence: 0.34

¬ Remarkable(beta blocker, be given before surgery) ⋁

Evidence: 0.65

¬ Typical(blood clot, form after knee surgery)

0.09

Rule weight: 0.14
Evidence weight: 0.74
Similarity weight: 0.91

Evidence: 0.34

¬ Remarkable(beta blocker, be given before surgery) ⋁

Evidence: 0.77

¬ Typical(blood clot, be risk after surgery)

0.09

Rule weight: 0.14
Evidence weight: 0.71
Similarity weight: 0.93

Evidence: 0.34

¬ Remarkable(beta blocker, be given before surgery) ⋁

Evidence: 0.85

¬ Typical(blood clot, happen after surgery)

0.09

Rule weight: 0.14
Evidence weight: 0.72
Similarity weight: 0.92

Evidence: 0.34

¬ Remarkable(beta blocker, be given before surgery) ⋁

Evidence: 0.83

¬ Typical(blood clot, be more likely after surgery)

...